Anti-Obesity Drugs Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1064885
  • May 2021
  • Pharmaceuticals
  • 121 Pages
The global Anti-Obesity Drugs market research report provides complete study and detail analysis of the market. This study includes forecast analysis of the market which is based on global and regional level, whereas the research reports the provides forecast data from 2020-2028 and historic of 2018 and 2019. All the values are based on revenue USD Million. Moreover, the market research report describes various segments of the Anti-Obesity Drugs market based on its types, applications and end-use industry. The applications of the market are explained in different industry verticals with reference to major countries across the globe. Along with this, the research report also covers all the major players that are operating in the global Anti-Obesity Drugs market. These major players of the market are further studied and analyzed based on various parameters, such as annual market revenue, annual sales of the company, marketing strategy, historic growth and shipment volumes. Based on all the company’s insights, the market research analyst also suggests business strategy and marketing plans for improving the market position of existing participants of Anti-Obesity Drugs market.
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered Arena Pharmaceuticals, Inc., F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc, Alizyme plc, Boehringer Ingelheim GmbH, Novo Nordisk A/S, Pfizer Inc, Shionogi Inc., Merck and Co., Inc., Norgine B.V.
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Impact Analysis
The analysis of covid-19 is based on the impact of the current pandemic situation on market scenarios. This includes impact of covid-19 outbreak on overall revenue, market segments as well as regional market. The report also puts light on detailed impact analysis by taking into consideration all the government policies imposed during the pandemic situation, temporary shutdown of manufacturing units, current state of supply chain and distributors, and its future impacts on the growth of overall market. The market study will assist user to understand the global demand and impose strategic business plans to compete with the peers.

Apart from this, the market research report also covers drivers and restraints for the global Anti-Obesity Drugs market and their impact on the demand and supply during the forecast period. Along with this, the research report also provides Anti-Obesity Drugs market trends and opportunities that are based on regional and global level. Furthermore, the market research report also provides the major distributors and manufacturers that are operating in all the key region across the world. The researched data provided in the report is widely used by various industry players to strengthen their distribution channel and improve the geographical reach. In addition, the report also covers all the major players of the global Anti-Obesity Drugs market and its key offerings and solutions. The report also provides recent mergers and acquisitions of these key players.

The data which is provided in the market research report is analyzed and evaluated with the help of various marketing tools, such as SWOT analysis, Poster’s Five Force analysis, PESTEL analysis, value chain analysis, player positioning analysis and market share analysis. Therefore, this analysis tools helps the analyst to evaluate the Anti-Obesity Drugs market based on various parameters such as capital investments, impact of consumer’s preferences, economies of scale, manufacturing rights and patents, existing distribution channels, switching costs, government regulations and brand loyalty.

Major Key Players for Global Anti-Obesity Drugs Market:
The Anti-Obesity Drugs market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Arena Pharmaceuticals, Inc., F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc, Alizyme plc, Boehringer Ingelheim GmbH, Novo Nordisk A/S, Pfizer Inc, Shionogi Inc., Merck and Co., Inc., Norgine B.V.

Anti-Obesity Drugs Market Segment Analysis:
By Drug Class
Peripherally Acting Anti-obesity Drugs
Centrally Acting Anti-obesity Drugs
Medication
Monotherapies
Polytherapies
Drug Type
Prescription Drugs
OTC Drugs


Geographic Coverage for Anti-Obesity Drugs Market:
The market research report on global Anti-Obesity Drugs market offers complete analysis across various regions across the world. The Anti-Obesity Drugs market is distributed into various regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa. The global leading market share as per the region is evaluated after considering Anti-Obesity Drugs market revenue, sales, shares, recent developments, innovations and growth rates. This section of regional analysis provides widespread evaluation of the industry from various countries and regions.

North America Anti-Obesity Drugs Market Value and Forecast
  • US
  • Canada
Europe Anti-Obesity Drugs Market Value and Forecast
  • UK
  • Germany
  • France
  •  Rest of Europe
Asia Pacific Anti-Obesity Drugs Market Value and Forecast
  • China
  • Japan
  • India
  • Rest of Asia Pacific
Latin America Anti-Obesity Drugs Market Value and Forecast
  • Mexico
  • Brazil
  • Rest of Latin America
Middle East and Africa Anti-Obesity Drugs Market Value and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa


Key highlights of the Anti-Obesity Drugs market report:
  • The report provides key trends of the global Anti-Obesity Drugs market
  • The report also covers consumer preferences and current industry growth
  • Key products or solutions offered by the main players in the Anti-Obesity Drugs industry
  • The report covers all the recent developments of the Anti-Obesity Drugs market and helps to provide current industry updates
  • The report covers a detailed look over the global Anti-Obesity Drugs Industry and provides with significant actionable insights
  • The Anti-Obesity Drugs market estimation from 2020-2028 and historical data for 2018 and 2019
  • The market study also provides data on changing market dynamics, market intelligence, current and future market trends
  • The report also analyses the microeconomic and macroeconomic factors that are affecting the global Anti-Obesity Drugs market
  • In-depth analysis of the market’s competitive landscape and detailed information about the vendors
  • The report also offers key market drivers, restrains, trends and opportunities with present and future impact on the market
  • Detailed information about the major players or manufacturers of the global Anti-Obesity Drugs market
  • Comprehensive analysis of the Anti-Obesity Drugs market segments based on its types, applications and end-use industry
Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Anti-Obesity Drugs market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Anti-Obesity Drugs market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

      2.  Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Anti-Obesity Drugs market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Anti-Obesity Drugs market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

      3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Anti-Obesity Drugs market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • Arena Pharmaceuticals, Inc.
  • F. Hoffmann-La Roche Ltd
  • GlaxoSmithKline plc
  • Alizyme plc
  • Boehringer Ingelheim GmbH
  • Novo Nordisk A/S
  • Pfizer Inc
  • Shionogi Inc.
  • Merck and Co., Inc.
  • Norgine B.V.
  • Peripherally Acting Anti-obesity Drugs
  • Centrally Acting Anti-obesity Drugs
  • Prescription Drugs
  • OTC Drugs

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Anti-Obesity Drugs Market Snapshot
          2.1.1. Global Anti-Obesity Drugs Market By Drug Class,2019
               2.1.1.1.Peripherally Acting Anti-obesity Drugs
               2.1.1.2.Centrally Acting Anti-obesity Drugs
          2.1.2. Global Anti-Obesity Drugs Market By Drug Type,2019
               2.1.2.1.Prescription Drugs
               2.1.2.2.OTC Drugs
          2.1.3. Global Anti-Obesity Drugs Market By End-use,2019
          2.1.4. Global Anti-Obesity Drugs Market By Geography,2019

3. Global Anti-Obesity Drugs Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Anti-Obesity Drugs Market Size (US$), By Drug Class, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Drug Class, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Drug Class, 2020
     4.2. Global Anti-Obesity Drugs Market Size (US$), By Drug Class, 2018 – 2028

5. Global Anti-Obesity Drugs Market Size (US$), By Drug Type, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Drug Type, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Drug Type, 2020
     5.2. Global Anti-Obesity Drugs Market Size (US$), By Drug Type, 2018 – 2028

6. Global Anti-Obesity Drugs Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Anti-Obesity Drugs Market Size (US$), By End-use, 2018 – 2028

7. Global Anti-Obesity Drugs Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Anti-Obesity Drugs Market Analysis, 2018 – 2028 
          7.2.1. North America Anti-Obesity Drugs Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Anti-Obesity Drugs Market Size (US$), By Drug Class, 2018 – 2028
          7.2.3. North America Anti-Obesity Drugs Market Size (US$), By Drug Type, 2018 – 2028
          7.2.4. North America Anti-Obesity Drugs Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Anti-Obesity Drugs Market Analysis, 2018 – 2028 
          7.3.1.  Europe Anti-Obesity Drugs Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Anti-Obesity Drugs Market Size (US$), By Drug Class, 2018 – 2028
          7.3.3. Europe Anti-Obesity Drugs Market Size (US$), By Drug Type, 2018 – 2028
          7.3.4. Europe Anti-Obesity Drugs Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Anti-Obesity Drugs Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Anti-Obesity Drugs Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Anti-Obesity Drugs Market Size (US$), By Drug Class, 2018 – 2028
          7.4.3. Asia Pacific Anti-Obesity Drugs Market Size (US$), By Drug Type, 2018 – 2028
          7.4.4. Asia Pacific Anti-Obesity Drugs Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Anti-Obesity Drugs Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Anti-Obesity Drugs Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Anti-Obesity Drugs Market Size (US$), By Drug Class, 2018 – 2028
          7.5.3. Latin America Anti-Obesity Drugs Market Size (US$), By Drug Type, 2018 – 2028
          7.5.4. Latin America Anti-Obesity Drugs Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Anti-Obesity Drugs Market Analysis, 2018 – 2028 
          7.6.1.  MEA Anti-Obesity Drugs Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Anti-Obesity Drugs Market Size (US$), By Drug Class, 2018 – 2028
          7.6.3. MEA Anti-Obesity Drugs Market Size (US$), By Drug Type, 2018 – 2028
          7.6.4. MEA Anti-Obesity Drugs Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Anti-Obesity Drugs Providers
        8.4.1 Arena Pharmaceuticals, Inc.
                8.4.1.1 Business Description
                8.4.1.2 Arena Pharmaceuticals, Inc. Geographic Operations
                8.4.1.3 Arena Pharmaceuticals, Inc. Financial Information
                8.4.1.4 Arena Pharmaceuticals, Inc. Product Positions/Portfolio
                8.4.1.5 Arena Pharmaceuticals, Inc. Key Developments
        8.4.2 F. Hoffmann-La Roche Ltd
                8.4.2.1 Business Description
                8.4.2.2 F. Hoffmann-La Roche Ltd Geographic Operations
                8.4.2.3 F. Hoffmann-La Roche Ltd Financial Information
                8.4.2.4 F. Hoffmann-La Roche Ltd Product Positions/Portfolio
                8.4.2.5 F. Hoffmann-La Roche Ltd Key Developments
        8.4.3 GlaxoSmithKline plc
                8.4.3.1 Business Description
                8.4.3.2 GlaxoSmithKline plc Geographic Operations
                8.4.3.3 GlaxoSmithKline plc Financial Information
                8.4.3.4 GlaxoSmithKline plc Product Positions/Portfolio
                8.4.3.5 GlaxoSmithKline plc Key Developments
        8.4.4 Alizyme plc
                8.4.4.1 Business Description
                8.4.4.2 Alizyme plc Geographic Operations
                8.4.4.3 Alizyme plc Financial Information
                8.4.4.4 Alizyme plc Product Positions/Portfolio
                8.4.4.5 Alizyme plc Key Developments
        8.4.5 Boehringer Ingelheim GmbH
                8.4.5.1 Business Description
                8.4.5.2 Boehringer Ingelheim GmbH Geographic Operations
                8.4.5.3 Boehringer Ingelheim GmbH Financial Information
                8.4.5.4 Boehringer Ingelheim GmbH Product Positions/Portfolio
                8.4.5.5 Boehringer Ingelheim GmbH Key Developments
        8.4.6 Novo Nordisk A/S
                8.4.6.1 Business Description
                8.4.6.2 Novo Nordisk A/S Geographic Operations
                8.4.6.3 Novo Nordisk A/S Financial Information
                8.4.6.4 Novo Nordisk A/S Product Positions/Portfolio
                8.4.6.5 Novo Nordisk A/S Key Developments
        8.4.7 Pfizer Inc
                8.4.7.1 Business Description
                8.4.7.2 Pfizer Inc Geographic Operations
                8.4.7.3 Pfizer Inc Financial Information
                8.4.7.4 Pfizer Inc Product Positions/Portfolio
                8.4.7.5 Pfizer Inc Key Developments
        8.4.8 Shionogi Inc.
                8.4.8.1 Business Description
                8.4.8.2 Shionogi Inc. Geographic Operations
                8.4.8.3 Shionogi Inc. Financial Information
                8.4.8.4 Shionogi Inc. Product Positions/Portfolio
                8.4.8.5 Shionogi Inc. Key Developments
        8.4.9 Merck and Co., Inc.
                8.4.9.1 Business Description
                8.4.9.2 Merck and Co., Inc. Geographic Operations
                8.4.9.3 Merck and Co., Inc. Financial Information
                8.4.9.4 Merck and Co., Inc. Product Positions/Portfolio
                8.4.9.5 Merck and Co., Inc. Key Developments
        8.4.10 Norgine B.V.
                8.4.10.1 Business Description
                8.4.10.2 Norgine B.V. Geographic Operations
                8.4.10.3 Norgine B.V. Financial Information
                8.4.10.4 Norgine B.V. Product Positions/Portfolio
                8.4.10.5 Norgine B.V. Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Anti-Obesity Drugs Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Anti-Obesity Drugs Market Revenue, By Drug Class, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Anti-Obesity Drugs Market Revenue, By Drug Type, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Anti-Obesity Drugs Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Anti-Obesity Drugs Market Revenue, By Drug Class, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Anti-Obesity Drugs Market Revenue, By Drug Type, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Anti-Obesity Drugs Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Anti-Obesity Drugs Market Revenue, By Drug Class, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Anti-Obesity Drugs Market Revenue, By Drug Type, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Anti-Obesity Drugs Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Anti-Obesity Drugs Market Revenue, By Drug Class, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Anti-Obesity Drugs Market Revenue, By Drug Type, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Anti-Obesity Drugs Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Anti-Obesity Drugs Market Revenue, By Drug Class, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Anti-Obesity Drugs Market Revenue, By Drug Type, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Anti-Obesity Drugs Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Anti-Obesity Drugs: Market Segmentation 
FIG. 2 Global Anti-Obesity Drugs Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Anti-Obesity Drugs Market, By Drug Class, 2019 (US$ Mn) 
FIG. 5 Global Anti-Obesity Drugs Market, By Drug Type, 2019 (US$ Mn) 
FIG. 6 Global Anti-Obesity Drugs Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Anti-Obesity Drugs Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Anti-Obesity Drugs Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Anti-Obesity Drugs Providers, 2019
FIG. 11 Global Anti-Obesity Drugs Market Revenue Contribution, By Drug Class, 2019 & 2028 (Value %) 
FIG. 12 Global Anti-Obesity Drugs Market Revenue Contribution, By Drug Type, 2019 & 2028 (Value %) 
FIG. 13 Global Anti-Obesity Drugs Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Anti-Obesity Drugs Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Anti-Obesity Drugs Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Anti-Obesity Drugs Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Anti-Obesity Drugs Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Anti-Obesity Drugs Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Anti-Obesity Drugs market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Anti-Obesity Drugs Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Anti-Obesity Drugs Market Value, By Segment1, 2018 – 2028
TABLE  North America Anti-Obesity Drugs Market Value, By Segment2, 2018 – 2028
TABLE  North America Anti-Obesity Drugs Market Value, By Country, 2018 – 2028
TABLE  Europe Anti-Obesity Drugs Market Value, By Segment1, 2018 – 2028
TABLE  Europe Anti-Obesity Drugs Market Value, By Segment2, 2018 – 2028
TABLE  Europe Anti-Obesity Drugs Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Anti-Obesity Drugs Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Anti-Obesity Drugs Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Anti-Obesity Drugs Market Value, By Country, 2018 – 2028
TABLE  Latin America Anti-Obesity Drugs Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Anti-Obesity Drugs Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Anti-Obesity Drugs Market Value, By Country, 2018 – 2028
TABLE  MEA Anti-Obesity Drugs Market Value, By Segment1, 2018 – 2028
TABLE  MEA Anti-Obesity Drugs Market Value, By Segment2, 2018 – 2028
TABLE  MEA Anti-Obesity Drugs Market Value, By Country, 2018 – 2028
TABLE  Arena Pharmaceuticals, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  F. Hoffmann-La Roche Ltd: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  GlaxoSmithKline plc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Alizyme plc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Boehringer Ingelheim GmbH: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Novo Nordisk A/S: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Pfizer Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Shionogi Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Merck and Co., Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Norgine B.V.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Anti-Obesity Drugs Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Anti-Obesity Drugs Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Anti-Obesity Drugs Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Anti-Obesity Drugs Market, By Geography, 2019 (US$ Mn)
FIG.  Global Anti-Obesity Drugs Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Anti-Obesity Drugs Providers, 2016
FIG.  Global Anti-Obesity Drugs Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Centrally Acting Anti-obesity Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Anti-Obesity Drugs Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global OTC Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Anti-Obesity Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Anti-Obesity Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Anti-Obesity Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Anti-Obesity Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Anti-Obesity Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Anti-Obesity Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Anti-Obesity Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Anti-Obesity Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Anti-Obesity Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Anti-Obesity Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Anti-Obesity Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Anti-Obesity Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Anti-Obesity Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Anti-Obesity Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Anti-Obesity Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Anti-Obesity Drugs Market Value, 2018 – 2028, (US$ Mn)